Aurobindo Pharma submits ANDA for generic dolutegravir

Biosimilars generic

Aurobindo Pharma, in conjunction with ViiV Healthcare and the Clinton Health Access Initiative Inc., have announced that Aurobindo has submitted an ANDA for generic dolutegravir to the FDA. Dolutegravir is a drug that is used to treat patients suffering from HIV. If the FDA approves the application, Aurobindo will begin to supply the generic version of the drug for the President’s Emergency Plan for AIDS Relief program.


Read the source article at Yahoo! Finance

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>